Celltrion, Foreign Investors Net Sell 14,860 Shares... Stock Price Down 2.02%
As of 12:30 PM on the 27th, Celltrion is trading at 329,000 KRW, up 2.02% from the previous day. This represents a 14.32% decline compared to January 12. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have net sold 14,860 shares of Celltrion, and institutions have net sold 13,000 shares, according to preliminary data. Over the past five days, individual investors have net bought 446,552 shares, while foreigners and institutions have net sold 256,104 shares and 206,387 shares, respectively.
On January 20, Celltrion became a market topic with the headline "Rebound six trading days after the announcement of the COVID-19 treatment clinical trial."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Contracts Signed Without Viewing at 1.6 Billion Won"... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- [Breaking] Blue House expresses "deep regret over Samsung negotiation breakdown... urges both sides to do their best for a final agreement"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
